To assess the possible roles of these cytokines in the suppressive activity of IMCs in the bone marrow of non-tumor-bearing mice, we added neutralizing antibodies to IL-4, IL-10 and TGFβ1 to cultures of mitogen activated T-cells co-cultured with CD11b+GR-1+ IMC. This evidence concerns the gene IL4 and neoplasm.